对于急性心肌梗塞的机械循环支使用的变化
Arjun Verma1,2, Nikhil L Chervu1, Justin J Kim1
1Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Heart (British Cardiac Society)
|August 24, 2025
概括
在急性心肌梗塞 (AMI) 与心脏性休克 (CS) 治疗中使用心血管气球 (IABP) 和穿皮室辅助装置 (PVAD) 存在医院间的差异. 医院因素影响设备选择,但资源利用在各中心保持相似.
科学领域:
- 心脏病学
- 干预心脏病学
- 医疗服务研究
背景情况:
- 急性心肌梗塞 (AMI) 后的心脏性休克 (CS) 是一种具有高死亡率的危急病.
- 机械循环支持,包括大动脉内气球 (IABP) 和穿皮室辅助装置 (PVAD),对于管理AMI CS至关重要.
- 缺乏IABP和PVAD部署的标准化算法,导致护理的潜在变化.
研究的目的:
- 评估AMI和CS患者使用IABP和PVAD的医院间差异.
- 确定与医院偏好IABP与PVAD相关的机构因素.
- 评估二次结果,例如升级到其他机械支持,停留时间和成本.
主要方法:
- 对2019年全国性再入院数据库的分析,用于AMI和CS的成人住院.
- 患者被分为IABP,PVAD和非机械循环支持组.
- 量化了医院间设备使用的差异,并分析了医院特征 (PCI量,安全网状态).
主要成果:
- 在53,903名患者中,23. 4%接受了IABP,12. 5%接受了PVAD.
- 中心水平差异约占IABP变化的13%和PVAD变化的18%.
- 高PVAD医院的PCI量较高,更有可能成为安全网机构;高PVAD中心的患者的ECMO或LVAD植入升级风险较低.
结论:
- 在AMI CS的机械循环支持 (IABP与PVAD) 的选择中存在显著的医院间差异.
- 医院的特点影响了设备的选择,但整体资源利用 (住院时间,费用) 是可比的.
- 虽然PVAD使用与减少进一步机械支持升级的需求有关,但需要进一步研究以优化设备选择协议.
相关概念视频
Blood Pressure Imbalances and Circulatory Shock
999
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
999
Cardiopulmonary Resuscitation IV: Pharmacological Management
75
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
75
Cardiomyopathy II: Dilated Cardiomyopathy
22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Acute Coronary Syndrome IV: Interprofessional Care
26
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
Cardiomyopathy V: Interprofessional Care
33
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33


